JP2020512373A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512373A5
JP2020512373A5 JP2019553478A JP2019553478A JP2020512373A5 JP 2020512373 A5 JP2020512373 A5 JP 2020512373A5 JP 2019553478 A JP2019553478 A JP 2019553478A JP 2019553478 A JP2019553478 A JP 2019553478A JP 2020512373 A5 JP2020512373 A5 JP 2020512373A5
Authority
JP
Japan
Prior art keywords
alkyl
amine
phenyl
compound
benzodiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019553478A
Other languages
English (en)
Japanese (ja)
Other versions
JP7674811B2 (ja
JP2020512373A (ja
Filing date
Publication date
Priority claimed from GBGB1705263.0A external-priority patent/GB201705263D0/en
Application filed filed Critical
Publication of JP2020512373A publication Critical patent/JP2020512373A/ja
Publication of JP2020512373A5 publication Critical patent/JP2020512373A5/ja
Priority to JP2022082769A priority Critical patent/JP7589191B2/ja
Priority to JP2024107135A priority patent/JP2024153639A/ja
Application granted granted Critical
Publication of JP7674811B2 publication Critical patent/JP7674811B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019553478A 2017-03-31 2018-04-03 新規の阻害剤 Active JP7674811B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022082769A JP7589191B2 (ja) 2017-03-31 2022-05-20 新規の阻害剤
JP2024107135A JP2024153639A (ja) 2017-03-31 2024-07-03 新規の阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1705263.0 2017-03-31
GBGB1705263.0A GB201705263D0 (en) 2017-03-31 2017-03-31 Novel inhibitors
PCT/EP2018/058391 WO2018178384A1 (en) 2017-03-31 2018-04-03 Novel inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022082769A Division JP7589191B2 (ja) 2017-03-31 2022-05-20 新規の阻害剤

Publications (3)

Publication Number Publication Date
JP2020512373A JP2020512373A (ja) 2020-04-23
JP2020512373A5 true JP2020512373A5 (enExample) 2021-05-20
JP7674811B2 JP7674811B2 (ja) 2025-05-12

Family

ID=58682483

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019553478A Active JP7674811B2 (ja) 2017-03-31 2018-04-03 新規の阻害剤
JP2022082769A Active JP7589191B2 (ja) 2017-03-31 2022-05-20 新規の阻害剤
JP2024107135A Pending JP2024153639A (ja) 2017-03-31 2024-07-03 新規の阻害剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022082769A Active JP7589191B2 (ja) 2017-03-31 2022-05-20 新規の阻害剤
JP2024107135A Pending JP2024153639A (ja) 2017-03-31 2024-07-03 新規の阻害剤

Country Status (14)

Country Link
US (3) US11339152B2 (enExample)
EP (1) EP3601269A1 (enExample)
JP (3) JP7674811B2 (enExample)
KR (2) KR102737532B1 (enExample)
CN (2) CN110719910B (enExample)
AU (2) AU2018246382C1 (enExample)
CA (2) CA3221839A1 (enExample)
EA (1) EA201992120A1 (enExample)
GB (1) GB201705263D0 (enExample)
IL (3) IL297534A (enExample)
MX (2) MX2019011544A (enExample)
NZ (1) NZ792694A (enExample)
WO (1) WO2018178384A1 (enExample)
ZA (1) ZA201905811B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2536650A (en) 2015-03-24 2016-09-28 Augmedics Ltd Method and system for combining video-based and optic-based augmented reality in a near eye display
US12458411B2 (en) 2017-12-07 2025-11-04 Augmedics Ltd. Spinous process clamp
US12521201B2 (en) 2017-12-07 2026-01-13 Augmedics Ltd. Spinous process clamp
WO2019211741A1 (en) 2018-05-02 2019-11-07 Augmedics Ltd. Registration of a fiducial marker for an augmented reality system
CN113166177B (zh) * 2018-10-05 2024-09-03 辉瑞公司 含硼的pde4抑制剂
US11766296B2 (en) 2018-11-26 2023-09-26 Augmedics Ltd. Tracking system for image-guided surgery
KR20210113648A (ko) * 2019-01-06 2021-09-16 소마젠 인크 Ｈｔｒａ 저해제 및 ｃａｇａ 저해제 및 이의 용도
US12178666B2 (en) 2019-07-29 2024-12-31 Augmedics Ltd. Fiducial marker
US11980506B2 (en) 2019-07-29 2024-05-14 Augmedics Ltd. Fiducial marker
US11382712B2 (en) 2019-12-22 2022-07-12 Augmedics Ltd. Mirroring in image guided surgery
KR102433502B1 (ko) * 2020-01-17 2022-08-18 재단법인 대구경북첨단의료산업진흥재단 신규 화합물, 이의 제조방법 및 이의 용도
WO2021145729A1 (en) 2020-01-17 2021-07-22 Daegu-Gyeongbuk Medical Innovation Foundation Novel compound, preparation method thereof, and use thereof
US11389252B2 (en) 2020-06-15 2022-07-19 Augmedics Ltd. Rotating marker for image guided surgery
US12502163B2 (en) 2020-09-09 2025-12-23 Augmedics Ltd. Universal tool adapter for image-guided surgery
US12239385B2 (en) 2020-09-09 2025-03-04 Augmedics Ltd. Universal tool adapter
WO2022086920A1 (en) * 2020-10-20 2022-04-28 Blacksmith Medicines, Inc. Glutaminyl-peptide cyclotransferase like (qpctl) protein inhibitors and uses thereof
MX2023006903A (es) * 2020-12-10 2023-06-26 Bayer Ag Acidos pirazol piperidin carboxilicos sustituidos.
US11896445B2 (en) 2021-07-07 2024-02-13 Augmedics Ltd. Iliac pin and adapter
US12150821B2 (en) 2021-07-29 2024-11-26 Augmedics Ltd. Rotating marker and adapter for image-guided surgery
US12475662B2 (en) 2021-08-18 2025-11-18 Augmedics Ltd. Stereoscopic display and digital loupe for augmented-reality near-eye display
CN117567435A (zh) * 2022-01-30 2024-02-20 上海市第十人民医院 谷氨酰胺环化酶抑制剂及其应用
WO2023205173A1 (en) * 2022-04-20 2023-10-26 Blacksmith Medicines, Inc. Substituted piperidines and substituted tetrahydropyridines as immune-modulating compounds
WO2023203521A1 (en) 2022-04-21 2023-10-26 Augmedics Ltd. Systems and methods for medical image visualization
CN114560817B (zh) * 2022-04-25 2022-10-25 北京大学第三医院（北京大学第三临床医学院） 一种用于抑制纤维化的小分子药物及其应用
AR130003A1 (es) * 2022-08-03 2024-10-23 Boehringer Ingelheim Int Derivados de piperidinilpiridinilcarbonitrilo como inhibidores de glutaminil-péptido ciclotransferasa y proteína tipo glutaminil-péptido ciclotransferasa
IL319523A (en) 2022-09-13 2025-05-01 Augmedics Ltd Augmented reality glasses for image-guided medical intervention
WO2024131742A1 (zh) * 2022-12-20 2024-06-27 深圳湾实验室 一种靶向usp1的小分子抑制剂及其应用
CN120359213A (zh) 2022-12-22 2025-07-22 勃林格殷格翰国际有限公司 作为谷氨酰胺酰肽环转移酶和谷氨酰胺酰肽环转移酶样蛋白的抑制剂的苯基哌啶衍生物
EP4680333A1 (en) 2023-03-13 2026-01-21 Boehringer Ingelheim International GmbH Phenylpiperidine derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like protein
WO2025031918A1 (en) 2023-08-04 2025-02-13 Boehringer Ingelheim International Gmbh Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like protein
AU2024322260A1 (en) 2023-08-04 2026-01-08 Boehringer Ingelheim International Gmbh Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like protein
AU2024325493A1 (en) 2023-08-14 2026-01-15 Boehringer Ingelheim International Gmbh Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like protein
CN117538462B (zh) * 2024-01-10 2024-03-26 地奥集团成都药业股份有限公司 一种氨氯地平贝那普利胶囊有关物质的检测方法
WO2025240620A1 (en) * 2024-05-14 2025-11-20 Pronovo Therapeutics Inc. Selective dual agonists of muscarinic 1 and 4 receptors and therapeutic uses thereof

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0640599T3 (da) * 1993-08-26 1998-09-28 Ono Pharmaceutical Co 4-Aminopyrimidin-derivater
US6262059B1 (en) * 1995-06-07 2001-07-17 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with quinazoline derivatives
US7642278B2 (en) * 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
JP2004536113A (ja) * 2001-07-03 2004-12-02 カイロン コーポレイション チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物
US8673924B2 (en) * 2002-09-04 2014-03-18 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
WO2005004818A2 (en) * 2003-07-09 2005-01-20 Imclone Systems Incorporated Heterocyclic compounds and their use as anticancer agents
ES2317031T3 (es) * 2003-07-16 2009-04-16 Janssen Pharmaceutica Nv Derivados de triazolopirimidina como inhibidores de la glucogeno-sintasa-quinasa 3.
AU2005205201B2 (en) * 2004-01-12 2011-05-12 Merck Serono Sa Thiazole derivatives and use thereof
US7875624B2 (en) * 2004-02-20 2011-01-25 Novartis Vaccines And Diagnostics, Inc. Modulating and measuring cellular adhesion
DE602005024274D1 (de) * 2004-07-16 2010-12-02 Sunesis Pharmaceuticals Inc Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
EP1797054A2 (en) * 2004-08-02 2007-06-20 OSI Pharmaceuticals, Inc. Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
GB0520958D0 (en) * 2005-10-14 2005-11-23 Cyclacel Ltd Compound
WO2007067537A1 (en) * 2005-12-07 2007-06-14 Osi Pharmaceuticals, Inc. Pyrrolopyridine kinase inhibiting compounds
JO2660B1 (en) * 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
AR060358A1 (es) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic Quinazolinas para la inhibicion de pdk 1
US7893058B2 (en) * 2006-05-15 2011-02-22 Janssen Pharmaceutica Nv Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
EP2049515B1 (en) 2006-07-14 2011-01-26 ChemoCentryx, Inc. Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis
AU2007336933A1 (en) * 2006-12-22 2008-07-03 Novartis Ag Heteroaryl-heteroaryl compounds as CDK inhibitors for the treatment of cancer, inflammation and viral infections
AU2007336893A1 (en) * 2006-12-22 2008-07-03 Novartis Ag Quinazolines for PDK1 inhibition
WO2008128986A1 (en) * 2007-04-18 2008-10-30 Probiodrug Ag Urea derivatives as glutaminyl cyclase inhibitors
JP5676249B2 (ja) * 2007-04-20 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体
EP2200436B1 (en) * 2007-09-04 2015-01-21 The Scripps Research Institute Substituted pyrimidinyl-amines as protein kinase inhibitors
CA2734486A1 (en) * 2008-08-20 2010-02-25 Southern Research Institute Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2344157B1 (en) * 2008-09-04 2016-05-25 Probiodrug AG Novel inhibitors
BR112012008346B1 (pt) * 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
WO2011107530A2 (en) * 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
DK2545047T3 (da) * 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
CN103298794A (zh) * 2010-11-09 2013-09-11 塞尔卓姆有限公司 作为tyk2抑制剂的吡啶化合物及其氮杂类似物
SG189043A1 (en) * 2010-11-10 2013-05-31 Hoffmann La Roche Pyrazole aminopyrimidine derivatives as lrrk2 modulators
US8785459B2 (en) * 2011-12-27 2014-07-22 Development Center For Biotechnology Quinazoline compounds as kinase inhibitors
CN104271569B (zh) * 2012-05-03 2016-08-24 霍夫曼-拉罗奇有限公司 作为lrrk2调节剂的吡唑氨基嘧啶衍生物
WO2014081718A1 (en) * 2012-11-20 2014-05-30 Genentech, Inc. Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants
EA029451B1 (ru) * 2013-03-15 2018-03-30 Пробиодруг Аг Новые ингибиторы
MA40957A (fr) * 2014-10-09 2017-09-19 Biomarin Pharm Inc Inhibiteurs de biosynthèse d'héparane sulfate pour traiter des maladies
EP3294729A1 (en) * 2015-05-13 2018-03-21 Selvita S.A. Substituted quinoxaline derivatives
JP2018527336A (ja) * 2015-08-10 2018-09-20 ファイザー・インク ３−インドール置換誘導体、医薬組成物、および使用方法
EP3394056B1 (en) * 2015-12-22 2021-04-14 Shy Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
US10034861B2 (en) * 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Similar Documents

Publication Publication Date Title
JP2020512373A5 (enExample)
IL307911A (en) New inhibitors
ES2358863T3 (es) Hetarilanilinas como moduladores de beta-amiloide.
JP5378532B2 (ja) 複素環γ−セクレターゼモジュレーター
JP4261914B2 (ja) 新規ベンジルピペリジン化合物
US20100298340A1 (en) Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies
WO2017023133A2 (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
JP2010524893A5 (enExample)
JP2010524896A5 (enExample)
KR20090024820A (ko) 인간 단백질 티로신 포스파타아제 억제제 및 이용 방법
JP2012502006A5 (enExample)
JP2013521325A5 (enExample)
PE20090297A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis
JP2010524899A5 (enExample)
JP2013521260A5 (enExample)
JP2010511013A5 (enExample)
CA2371274A1 (en) Selective npy (y5) antagonists
JP2010524895A5 (enExample)
CA2553705A1 (en) 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
JP2010509284A5 (enExample)
JP2015509510A5 (enExample)
EA022420B1 (ru) Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5)
JP2003532730A (ja) 細胞増殖抑制剤として有用な１，１−ジオキソイソチアゾリジンを持つインダゾール
JP2010524898A5 (enExample)
WO2007063925A1 (ja) ２－アミノベンズアミド誘導体